Kaplan Fox Alerts Investors: Lead Plaintiff Deadline for Hims & Hers Health, Inc. (HIMS) is November 2, 2026

Impact · against what's priced in

The lead plaintiff deadline for the HIMS class action is a procedural update that does not fundamentally alter the current valuation, as the market has already integrated the risk of regulatory friction and legal drag. While it confirms the persistence of these liabilities, it provides no new catalyst to shift the existing bearish lean.

HIMS−0.05

Already priced in

The price assumes

Significant legal and regulatory friction, including FTC lawsuits over data privacy and billing practices.